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Chronic pain is of significant global concern. There is growing evidence that body-mind therapies and psychological approaches can
contribute towards changing chronic pain perceptions. This is the first model described in the literature that combines a
mindfulness-based approach with dance movement therapy, and explores potential psychological and pain-related changes for this
client population. In this paper results from the pilot study are presented involving patients with chronic headache recruited in an
outpatient rehabilitation setting.  
Methods: In this pilot study 29 patients (n=29) with chronic headache were randomized to either an MBDMT group or a waiting list
control group (TAU). The MBDMT group was offered ten sessions in a clinical outpatient rehabilitation setting for five weeks. Data
were collected pre- and post-intervention and 16 weeks after the intervention finished. The Hospital Anxiety and Depression scale
(HADS), Patient Health questionnaire (PHQ-9), Five Facets of Mindfulness questionnaire (FFMQ) and Numeric Pain rating scale (NRS)
were used as outcome measures.  
Results: The working model of MBDMT identifies nine therapeutic mechanisms (safe therapeutic environment, mindfulness skills,
body awareness, relaxation / releasing, distancing and staying with discomfort, meaning making, self-regulation, acceptance and
integration, creative process). Per-protocol analysis reveals statistically significant reduction of pain intensity and depression
scores in favor of the MBDMT group and these improvements were maintained in follow-up assessment.
Conclusions: Results suggest that MBDMT is a feasible and promising therapy approach for chronic pain patients. The pilot study
offered sufficient information and preliminary results in the desirable direction to enable the researchers to move to an RCT stage
in order to establish the efficacy of the intervention.
Trial registration: the study was registered in the www.researchregistry.com registry (5483).
  
 Contribution to the field
This paper reports results of the development of Mindful-Based Dance movement therapy (MBDMT) approach for chronic pain
patient population. Mindfulness is recognized as important component in dance movement therapy (DMT), but there has not been
model which explores and integrates therapeutic mechanisms of both approaches - DMT and mindfulness-based interventions. The
paper presents model of the MBDMT and results from pilot study where MBDMT intervention was offered to chronic headache
patients recruited in an outpatient rehabilitation setting. In study design grounded theory was used to develop MBDMT model and
quantitative strategy of pilot randomized controlled study was used to examine the effectiveness of the model. The preliminary
results suggest that MBDMT is effective in reducing pain intensity and depression symptoms in comparison with TAU group. Also,
important information was gained regarding recruitment and follow-up processes, intervention acceptability and participant
satisfaction, outcome measure acceptability and performance. The pilot study offered sufficient information and preliminary
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Abstract 9 
Chronic pain is of significant global concern. There is growing evidence that body-mind therapies 10 
and psychological approaches can contribute towards changing chronic pain perceptions. This is the 11 
first model described in the literature that combines a mindfulness-based approach with dance 12 
movement therapy, and explores potential psychological and pain-related changes for this client 13 
population. In this paper results from the pilot study are presented involving patients with chronic 14 
headache recruited in an outpatient rehabilitation setting.   15 
Methods: In this pilot study 29 patients (n=29) with chronic headache were randomized to either an 16 
MBDMT group or a waiting list control group (TAU). The MBDMT group was offered ten sessions 17 
in a clinical outpatient rehabilitation setting for five weeks. Data were collected pre- and post-18 
intervention and 16 weeks after the intervention finished. The Hospital Anxiety and Depression scale 19 
(HADS), Patient Health questionnaire (PHQ-9), Five Facets of Mindfulness questionnaire (FFMQ) 20 
and Numeric Pain rating scale (NRS) were used as outcome measures.   21 
Results: The working model of MBDMT identifies nine therapeutic mechanisms (safe therapeutic 22 
environment, mindfulness skills, body awareness, relaxation / releasing, distancing and staying with 23 
discomfort, meaning making, self-regulation, acceptance and integration, creative process). Per-24 
protocol analysis reveals statistically significant reduction of pain intensity and depression scores in 25 
favor of the MBDMT group and these improvements were maintained in follow-up assessment.  26 
Conclusions: Results suggest that MBDMT is a feasible and promising therapy approach for chronic 27 
pain patients. The pilot study offered sufficient information and preliminary results in the desirable 28 
direction to enable the researchers to move to an RCT stage in order to establish the efficacy of the 29 
intervention. 30 
Trial registration: the study was registered in the www.researchregistry.com registry (5483). 31 
 32 
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Chronic pain affects 20% of the worldwide population (Fayaz et al., 2016;  Goldberg & McGee, 34 
2011). 150 million Europeans suffer from moderate to severe chronic pain (Thematic Network on the 35 
Societal Impact of Pain, 2018)1. This debilitating condition affects persons’ physical, emotional and 36 
social functioning, being a major source of suffering at the same time as it is a significant economic 37 
burden and challenge for health care systems (IASP, 2019)2. Since 2019 a significant change has 38 
been made in the classification of chronic pain as the World Health Organization has adopted the 39 
new edition of ICD-11. ICD-11 will be the first classification to include chronic pain as a health 40 
condition in its own right. This new classification differentiates chronic primary pain from chronic 41 
secondary pain, with the former referring to pain in one or more anatomical regions that persists or 42 
recurs for longer than three months.  Furthermore, it recognizes that chronic primary pain is closely 43 
linked with significant emotional distress (anxiety, anger/frustration or depressed mood) and it 44 
interferes with the activities of daily life and participation in social roles in ways in which cannot be 45 
accounted for by another chronic pain condition (ICD-11, 2018)3. The new classification system is 46 
expected to promote research on the etiology and pathophysiology of these conditions and to improve 47 
access to multimodal care for all patients with chronic pain (Treede et al., 2019). Several emotional 48 
distress factors are regarded as mediators in the ‘chronification’ of pain, that is persistent pain with 49 
characteristic pain behavior and resistance to therapeutic intervention (Borsook et al., 2018). These 50 
factors include pain catastrophizing, anxiety, and fear of pain and helplessness (Keefe et al, 2004). 51 
Depression is also seen as a serious risk factor in the development of debilitating pain (Hülsebusch et 52 
al., 2016). The psychological characteristics of chronic pain patients can involve abuse and neglect 53 
experiences in childhood (Davis et al., 2005), counter-dependency traits and alexithymia (Ak et al., 54 
2004), with depression working as a mediator between chronic pain and alexithymia (Saariaho et al., 55 
2013). These psycho-emotional characteristics of chronic pain patients make this patient population 56 
quite a heterogenous group. The large-scale cross-sectional study of chronic pain patients identified 57 
four subgroups. They differ in aspects of pain intensity, duration and spreading, psychological strain 58 
and social distress including lack of social support. Research confirms that all three components – 59 
bio-psycho-social – are important in chronic pain, but different constellations of these components 60 
form subgroups with different needs in pain treatment and indicate the need to design “tailor-made” 61 
interventions (Bäckryd et al., 2018). 62 
 63 
Epidemiology studies show that the prevalence of pain is higher in women: chronic primary 64 
headache, in particular, affects more women than men (Jiménez-Sánchez et al., 2012; Allais et al., 65 
2020). Middle-age (40-59) has been reported as high-risk: people in this group appear to be less 66 
satisfied with their social life and are more often diagnosed with fibromyalgia. The older adult group 67 
reported higher life quality scores, higher levels of satisfaction with marital and social life, and better 68 
mood, but they face more comorbidities and longer periods of pain (Rustøen at al., 2005). Seniors 69 
also report lower levels of pain severity and pain interference and greater levels of perceived control 70 
over pain in comparison to younger people suffering from headaches (Lachapelle & 71 
Hadjistavropoulos, 2005).  72 
 73 
                                               
1 Thematic Network on the Societal Impact of Pain, 2018: 
https://ec.europa.eu/health/sites/health/files/policies/docs/ev_20181112_co07_en.pdf 
2 IASP, 2019: https://www.iasp-
pain.org/PublicationsNews/NewsDetail.aspx?ItemNumber=8340&navItemNumber=643 
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Treatment strategies which are regarded as clinically effective, and cost-efficient, tend to be 74 
multidisciplinary and are based on the biopsychosocial model of pain (Gatchel et al., 2007), 75 
acknowledging psychological risk factors (Nicholas et al, 2011) and offering holistic approaches to 76 
multimodal pain management (Kress et al., 2015). The biopsychosocial model of pain recognizes that 77 
pain has three facets: cognitive-evaluative, sensory-discriminative, and affective-motivational aspects 78 
(Melzack, 1999). All of these need to be included in a treatment package. From a wide range of 79 
psychological therapies, Cognitive Behavioral therapy (CBT) and Acceptance and Commitment 80 
Therapy (ACT) present the strongest evidence for decreasing depression, pain-related anxiety and 81 
catastrophizing, and for increasing self-efficacy (Williams et al., 2012; Veehof et al., 2016). Also, 82 
studies on Mindfulness-Based Stress Reduction programme (MBSR) report decreasing pain intensity 83 
and disability (Cramer et al., 2012). MBSR was a programme created and introduced by John Kabat-84 
Zinn, who defines mindfulness as: “the awareness that emerges through paying attention on purpose, 85 
in the present moment, and nonjudgmentally to the unfolding of experience moment to moment” 86 
(Kabat-Zinn, 2003, p.145). Mindfulness allows patients to relate to their physical and psychological 87 
symptoms in a different, more skillful way, with a positive effect on developing a realistic sense of 88 
control and appropriate strategies in becoming adaptive (Grossman et al., 2010; Kabat-Zinn et al., 89 
1986). Other Mindfulness-Based Interventions (MBI) show positive impact on perceived pain 90 
control, pain acceptance and quality of life (Bawa et al., 2015). In MBIs the indirect effect on pain is 91 
due to an increased acceptance; this buffers the intensity of perceived pain as a stressful event 92 
(Shapiro et al., 2006). Analysis of the content of MBIs reveal meditation practice, exercises that 93 
support the change of habits, simple yoga exercises and psychoeducation as some of the main 94 
structural components of the intervention (Majore-Dūšele et al., 2018).  Furthermore, monitoring 95 
attention and acceptance are the central mechanisms in mindfulness training programmes; 96 
these interact to improve stress, affect, and health outcomes (Lindsay & Creswell, 2017).   97 
 98 
However, these interventions are limited in their capacity to approach the person as a whole, 99 
prioritizing often the cognitive domain as the route through which change may occur. They 100 
require considerable cognitive and linguistic skills from the client/patient and acknowledgment of 101 
psychological difficulties and mental health concerns in their physical symptoms. As chronic pain 102 
patients experience the physical nature of their symptoms, and may perceive their mental health 103 
concerns as stigma, they may refuse cognitive-based interventions (Payne & Brooks, 2018). With 104 
chronic pain being situated in the body, there is a danger that cognitive-based interventions are 105 
missing the opportunity to validate the physical suffering and work with the body in order to find 106 
therapeutic solutions. They also make limited use of the connection between the body and the mind 107 
as a means through which change may occur, ignoring the role movement can play as a holistic, 108 
creative, and thus therapeutic, tool. For a body-based condition such as chronic pain, there may be 109 
value in the development of a body-mind intervention with a holistic/creative character. Dance 110 
Movement Therapy (DMT) is one such intervention.  111 
 112 
DMT is defined as “the therapeutic use of movement to further the emotional, cognitive, physical, 113 
spiritual and social integration of the individual. Somatic awareness and kinesthetic empathy, 114 
movement as creative self-expression and dance as non-verbal interaction, are the core components 115 
of DMT (European Association of Dance Movement Therapy 2013, p.1)4.  116 
 117 
                                               
4 European Association of Dance Movement Therapy, 2013: 
https://www.eadmt.com/?action=article&id=22 
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There is growing evidence that Dance Movement Therapy (DMT), a creative body-mind form of 118 
psychotherapy, may have a positive psychological impact on the psychological states of patients with 119 
somatic concerns.  Dance and movement, being key elements in the therapeutic alliance between 120 
patient and therapist, can provide the means for the self-expression and communication of unspoken 121 
concerns amongst this client population. The latest	meta-analyses show that DMT is helpful in 122 
health-related psychological outcomes, improving wellbeing, mood, affect, quality of life, body 123 
image and interpersonal competence, and reducing clinical symptoms such as anxiety and depression 124 
for different patient groups (Koch et al., 2014; Koch et al., 2019; Meekums et al., 2015; Karkou et 125 
al., 2019). DMT has shown promising improvements in functioning for fibromyalgia patients 126 
(Bojner-Horwitz et al., 2003) and patients with medically unexplained symptoms (Payne & Brooks, 127 
2020; Payne & Brooks, 2017; Payne & Brooks, 2016). However, until now, there has been limited 128 
research on the effectiveness of DMT with patients suffering chronic pain. One of the few studies 129 
with this client population comes from Shim (2015; Shim, et al., 2017) who found that the ten-week 130 
DMT process increased resilience, decreased ‘kinesiophobia’ (i.e. fear of movement) and showed a 131 
beneficial impact on pain intensity.  132 
 133 
Regardless of the type of psychological therapy, there are arguments that the mechanisms of change 134 
in each therapeutic intervention need to be considered specifically for each client population (Kazdin, 135 
2009; Burns, 2016). In pain treatment mindfulness, acceptance and self-efficacy are recognized 136 
mechanisms in pain regulation (Turner et al., 2016). In DMT work with chronic pain patients, 137 
increasing self-compassion has been set as a main principle of the work, which is facilitated through 138 
alternating between states of acceptance and inspiration (Erber, 2015). The BodyMind Approach® 139 
(TBMA) (an approach that has derived from DMT) has identified five key factors as responsible for 140 
successful self-management of patients with medically unexplained symptoms. These are: body with 141 
mind connections, importance of the facilitator, positive benefits, preparedness for change, self-142 
acceptance and compassion (Payne & Brooks, 2020). The DMT model for building resilience in pain 143 
patients by Shim et al, (2017) recognizes the mechanisms of activating self-efficacy, connecting to 144 
self, connecting to others, enhancing emotional intelligence, and reframing as important. In earlier 145 
models of DMT for chronic pain patients (Shim, 2015), four therapeutic factors were identified: 146 
kinesthetic awareness (articulation, noticing, widening), enactment (mobilization & motivation, 147 
kinesthetic imagining, reinforcement & reframing), expressivity (externalizing & symbolization, 148 
emotional restoration and management, creativity & ability to play), and making connections (mind-149 
body integration, meaning-making & identity reconstruction, interpersonal connection). 150 
 151 
Despite the discussion in DMT literature that mindfulness is an important component of DMT (Koch 152 
et al., 2019), there has been no prior study that integrates these two approaches and explores potential 153 
psychological and pain-related changes for this client population. In this paper the development of 154 
the working model of the Mindful-Based DMT (MBDMT) is presented, along with results from the 155 
pilot study that has been completed, before conducting a large RCT that will examine the efficacy of 156 
MBDMT for chronic pain patient population.  157 
 158 
The objectives of the pilot study were to: (1) establish recruitment and follow-up processes; (2) 159 
explore initial outcome results of MBDMT intervention; (3) examine intervention acceptability, 160 
participant adherence and (4) test adherence to the MBDMT protocol. This current paper will present 161 
and discuss how these objectives were met. 162 
2 Methods 163 
2.1. Recruitment procedure and participants 164 
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The present study recruited patients with chronic headache (tension-type headache and/or migraine 165 
with or without aura, diagnosed by neurologist). Patients with chronic headache were prioritized in 166 
this study because of easy access to this population in the first instance. Inclusion and exclusion 167 
criteria were established prior to the commencement of the study. Inclusion criteria for the study 168 
were: (1) primary headache lasting more than three months (headaches needed to be the primary 169 
cause for seeking medical help); (2) being between 20 and 55 years old; (3) increased depression 170 
and/or anxiety measures (PHQ-9 ≥ 5; HADS ≥ 7). Exclusion criteria were: (1) patients who had a 171 
disease based on an infectious process, autoimmune or metabolic pathology, traumatic injury, 172 
neoplastic process (primary tumor or metastasis) or internal organ pathology which can be connected 173 
with pain; (2) movement limitations not related to the diagnosis of chronic pain (eg cerebral palsy, 174 
spinal injuries, etc.); (3) pregnancy.  175 
The recruitment strategy involved: (i) the neurologists of the rehabilitation setting who were 176 
informed at their quarterly meeting about the aims and structure of the intervention, and the inclusion 177 
and exclusion criteria of the pilot study; (ii) participation in the research and DMT groups was 178 
advertised through social media in a closed group of the headache patient’s association. Interested 179 
participants allowed their neurologist to send contact information to the principal investigator (first 180 
author of this paper). Alternatively, they were given the option to contact the principle investigator 181 
themselves through email or SMS. The principal investigator made an initial phone call to each 182 
interested individual to inform them about the study, to answer any questions, and to gain verbal 183 
consent for participation in the study. Potential participants were informed about randomization, and 184 
were also informed that members of the control group could participate in the DMT group after the 185 
intervention group process was complete. Following this, all participants were sent by email written 186 
information about the study, the consent form and all measures for the baseline assessment. The 187 
recruitment process and all aspects of the study gained ethical approval by the Ethics Committee of 188 
Riga Stradins University (02/28/2019 Nr,6-3/2/43). 189 
Over the ten weeks of the recruitment period (Aug-Nov 2019), 39 women (n=39) expressed interest 190 
in participating in the study; 19 were recommended for participation by their neurologists, while the 191 
other 20 were recruited through the headache patient’s association. Although no prevalence or 192 
restrictions were identified in inclusion criteria regarding sex, only female participants came forward 193 
to participate in the study. After the baseline assessment, 29 patients (n=29) were eligible for 194 
inclusion. These patients were randomly assigned to the MBDMT intervention or the waiting list 195 
control group using the random number generator that produced two sets of 15 unique numbers from 196 
1-30. 197 
 198 
All participants in the study received treatment as usual (TAU), continuing in their rehabilitation 199 
outpatient setting. TAU for chronic headache patients was pharmacological treatment ordered by a 200 
neurologist along with physical and/or physiotherapy input (Table 1).  201 
Figure 1 Recruitment flow diagram (insert here) 202 
2.2. Outcome measures 203 
Assessments were performed at baseline (T1), post treatment (T2; 2 months after baseline) and four 204 
months post-intervention (T3; 4-month follow-up). 205 
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Demographic information was collected through a self-completed questionnaire created by the 206 
researcher, which gathered information about the gender, age and pain characteristics - pain duration, 207 
pain etiology, and types of pain control strategies.  208 
A numeric rating scale (NRS) was used as a scale for pain intensity measurement. This is an 11-point 209 
scale where the end points are the extremes of no pain (0) and worst possible pain (10). The NRS can 210 
be graphically or verbally presented, and can be self-assessed. This method of assessing pain is 211 
widely recommended as a core outcome measure in clinical trials of chronic pain treatment 212 
(Dworkin, et al., 2005; Farrar, et al., 2001). 213 
The Hospital anxiety and depression scale (HADS; Zigmond & Snaith, 1983) evaluates the severity 214 
of anxiety and depression symptoms in non-psychiatric inpatients. It is composed of seven items that 215 
assess anxiety symptoms and seven for depression symptoms. Each item contains a scale of four 216 
points (from 0 to 3) with total scores ranging from 0 to 21 for anxiety and depression in three 217 
categorical levels: normal (0–7); borderline abnormal (8–10); abnormal (11–21). Higher scores mean 218 
greater severity. Psychometric properties for the Latvian version showed a good internal consistency 219 
(Cronbach’s alpha 0.892) (Šmite & Ancāne, 2010). In the present study, the internal consistency at 220 
T1 was Cronbach’s α = .82 for depression scale and α = .80 for anxiety scale; at T2 α = .79 and α = 221 
.82; at T3 α = .74 and α = .73. 222 
The 9-items Patient Health Questionnaire (PHQ-9; Kroenke & Spitzer, 2002) is a self-administered 223 
dual-purpose instrument that can establish provisional depressive disorder diagnoses as well as grade 224 
depressive symptom severity. Each of the nine items is scored 0 to 3, providing a severity score 225 
ranging from 0 to 27. Severity of depression was assessed by the PHQ-9 depression severity score 226 
and graded as none/minimal (0-4), mild (5-9), moderate (10-14), moderately severe (15-19), and 227 
severe (20-27). In the present study, the internal consistency of T1 data was Cronbach’s α =.79; T2 α 228 
=.74; T3 α =.70 229 
 230 
The Five facets of mindfulness questionnaire (FFMQ; Baer et al., 2006) is composed of 39 items. 231 
Each item is rated on a 5-point Likert scale (1 = “never or very rarely true”; 5 = “very often or always 232 
true”). Five scales: “Observing” is the ability to notice or attend to internal and external experiences 233 
such as sensations, thoughts, or emotions. “Describing” means to label internal experiences with 234 
words. “Acting with awareness” refers to focusing on one’s activities in the moment as opposed to 235 
behaving mechanically. “Non-judging of inner experience” means taking a non-evaluative stance 236 
toward thoughts and feelings and “non-reactivity to inner experience” refers to allowing thoughts and 237 
feelings to come and go, without getting caught up in or carried away by them. Higher scores on the 238 
FFMQ reflect greater mindfulness skills. The Latvian version of this scale has shown good reliability 239 
and internal consistency (Cronbach’s alpha 0.9; Majors, 2013). In the present study, the internal 240 
consistency of T1 data was Cronbach’s α =.89; T2 α =.86; T3 α =.91. 241 
Intervention  242 
The Mindful-Based Dance Movement Therapy (MBDMT) intervention model used in this study was 243 
grounded on the contribution of five expert informants. It involved nine therapeutic 244 
mechanisms/components of change, which were structured in a developmental process with each 245 
component supporting the next one.  246 
1. Safe therapeutic environment. This is a common factor in any counselling or psychotherapy 247 
process. Its main characteristics are warm relationships built on empathy, support, validation and the 248 
acceptance of the patient as he/she is – emotionally, physically, and cognitively. These are also 249 
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known as the person-centered facilitative conditions (Lambert & Barley, 2001). The therapeutic 250 
environment is a safe holding space for the other factors in the therapy process.  251 
2. Mindfulness skills. The patient will be supported to focus and regulate their attention to different 252 
realms of perception: their own sensations, emotions, thoughts and images, and to cultivate kindness, 253 
compassion and a non-judgemental attitude towards their self. The development of mindfulness skills 254 
will serve as gateway into the creative process.  255 
3. Body awareness. The patient will pay attention toward their body sensations, not reacting 256 
negatively or emotionally but with an explorative interest. Attention toward interaction between 257 
sensation, emotions and thoughts, experience of body-mind connectivity.  258 
4. Relaxation / releasing. Through creative activities, verbalization and sharing, the patient will 259 
express themselves safely and release physical tension. This will open them up for new experiences 260 
and perceptions of themselves and others.  261 
5. Distancing and staying with discomfort. Instead of persisting with fear and avoidance reactions, 262 
the patient will use creative tools (props) and aesthetic distance to focus on pain. This will help them 263 
to explore their relationship with their symptoms, and to build tolerance and the ability to manage 264 
their discomfort.  265 
6. Meaning making. The patient will be invited to respond to the question: ‘Why is this happening to 266 
me?’ In-depth exploration of symptoms in the context of one’s personal life and possible insights into 267 
the cause-effect relationship of symptom development.  268 
7. Self-regulation. The patient will practice self-management, recognizing and releasing physical 269 
tension and dealing with any emotionally intense feelings which may arise.  270 
8. Acceptance and integration. As a result of the therapeutic process, the patient may gain a deeper 271 
understanding of themselves, as well as an acceptance of their physical and emotional state.  272 
9. The Creative process permeates all of the above factors in the model, as they are delivered through 273 
creative activities. Imagery, symbolism and movement metaphors are core aspects of dance 274 
movement therapy.  275 
 276 
The therapy model described above shows that MBDMT is a purposefully organized therapeutic 277 
process where, through the use of creative activities, the development of mindfulness skills, and an 278 
exploration of bidirectional processes, the relationship between body and mind is explored and self-279 
management and self-regulation skills are learned (Majore-Dūšele et al., 2019). 280 
 281 
Figure 2 Mindful-Based Dance Movement therapy intervention model (insert here) 282 
 283 
The protocol of the MBDMT intervention is organized as a short-term focused therapeutic process 284 
taking into the account the short-term organization structure of rehabilitation settings in Latvia.  It 285 
includes ten sessions, twice a week, for a five-week period. Each session lasts 90 minutes and 286 
follows a similar structure: (1) check-in and physical warm-up; (2) body-scan (sitting, lying, 287 
standing, or walking); (3) work with themes – safety, pleasure, personal borders, body-mind 288 
connection, relationship with pain, resources; (4) closure and homework.  289 
Two therapeutic groups took place, with seven/eight participants in each group. Three participants 290 
were lost early in the process, leaving a group of twelve (n=12) from whom the data was derived. 291 
The groups were facilitated by a dance movement therapist in training (3rd year professional Masters 292 
student in arts therapies with specialization in dance movement). The facilitator had been licensed as 293 
a psychotherapist prior to training as a dance movement therapist, had more than five years practice 294 
working with mental health issues and adult groups, had previous mindfulness practice training (8 295 
weeks programme), received training in delivering the MBDMT intervention (24 hrs) and had 296 
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supervision during the intervention period by a qualified supervisor. MBDMT intervention training 297 
included personal experience with the MBDMT model and facilitating skills training.  298 
2.3. Analysis 299 
Data were analyzed using the Statistical Package for Social Science – Version 23 (SPSS-23, IBM 300 
SPSS Statistics for Macintosh, Version 23.0. Armonk, NY, United States: IBM Corp.). Descriptive 301 
statistics were used to present the characteristics of the sample. The Kolmogorov-Smirnov test 302 
indicated that the distribution departed from normality and the small sample size limited the power of 303 
statistical analysis, so the Mann-Whitney U test was used to analyze baseline group differences of the 304 
interval data (ie socio-demographic and clinical characteristics), while the Pearson Chi-Square test or 305 
Fisher’s Exact Test was used for categorical variables (localization and duration of pain and pain 306 
control strategies). The Mann-Whitney U test was also used to conduct a between-group comparison 307 
of the change in scores from baseline (T1) to the post treatment (T2) and follow up (T3) for all the 308 
outcome measures with p < 0.05 being the accepted level of statistical significance. Although 309 
medians (interquartile range) were used for the calculation of averages, also means and standard 310 
deviations were presented. Taking into account the small sample size of this pilot study, the statistical 311 
analysis was performed Per Protocol (PP) instead of performing Intention To Treat (ITT) analysis.  312 
PP included patients who completed the intervention according to the protocol only along with data 313 
collected from the control group. In all cases, missing data were not included in the calculation.   314 
 315 
The Reliable Change Index (RCI; Jacobson & Truax, 1991) was calculated for PHQ-9, HADS and 316 
pain measures to assess the impact of the intervention at the individual level. RCI was used as an 317 
indicator of clinical significance of change because it allowed a determination of whether an 318 
individual change score (between pre-intervention and post-intervention assessment) was 319 
significantly greater than a difference that could have occurred due to random measurement error 320 
alone (Guhn et al., 2014). Cut-off points dividing clinical and non-clinical patient groups were ≥10 321 
for PHQ-9 and ≥8 for HADS as the most frequently recommended ones in the literature (Manea et 322 
al., 2012; Hansson et al., 2009; Bjelland et al., 2002). Participants whose PHQ-9 and HADS scores 323 
were below the cut-off point at the pre-treatment measurement (T1) were excluded from the RCI 324 
calculation. RCI were calculated at 95% confidence. If a participant’s RCI was below –1.96 and 325 
passed the cut-off point, the participant was classified as recovered. If the RCI was below –1.96 but 326 
did not passed the cut-off point, the participant was classified as improved. If the participant’s RCI 327 
was between –1.96 and 1.96, the participant was classified as unchanged. If the participant’s RCI 328 
was above 1.96, the participant was classified as deteriorated. For pain measures the RCI were 329 
calculated based on the minimal clinically important difference being 2-points on a 10-point rating 330 
scale as reported in previous studies (Hägg et al., 2003).  331 
 332 
Power calculation was performed for the primary outcome measure – depression (PHQ-9), to detect 333 
the adequate sample size for future RCT.   334 
3 Results  335 
3.1. Recruitment and follow-up feasibility 336 
 337 
During the 2.5-month enrollment period, 39 women expressed an interest in participating in the study 338 
and 29 met the eligibility criteria. Both recruitment strategies (i) by the neurologists and (ii) by 339 
headache patients’ association were similarly effective, attracting 50% and 50% of study participants. 340 
As the study flow diagram shows (see Figure 1), post-treatment measures used immediately after the 341 
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intervention were completed by all the members of the control group and all those from the 342 
intervention group who attended for the whole duration of the programme. Three participants who 343 
did not complete therapy discontinued early in the study. Follow-up measures were completed by 344 
100% of the intervention group completers and 71% (10/14) of the control group. 345 
 346 
Sample characteristics 347 
 348 
All the participants in the study were female and between 26 and 55 years of age (M = 36.7, 349 
SD=7.4). 56.7% of the patients had suffered from pain (headache, migraine) for more than ten years. 350 
60% of the patients suffered from other types of pain in addition to headache and migraine. The 351 
participants in the intervention and control group were compared by demographic characteristics in 352 
order to establish whether there were differences between them at baseline. The participants in the 353 
intervention group were older (M = 40.9, SD= 6.9) than participants in the control group (M = 32.6, 354 
SD= 5.0). There were no differences between the two groups in the duration of pain experience and 355 
variabilities of pain type or pain control strategies (Table 1).  356 
 357 
Table 1: Baseline participant demographic and clinical characteristics in intervention and control 358 
groups (insert here). 359 
3.2. Treatment outcome results: changes in intervention group versus control group 360 
Table 2 Means, standard deviation, medians of clinical outcome measures; between group 361 
comparison of the pre/post and pre/follow up change scores (per-protocol analysis) (insert here). 362 
 363 
The means, standard deviation and medians of the outcome measures, as well as between group 364 
comparison of the baseline/post (T1/T2) and baseline/follow up (T1/T3) change scores are presented 365 
in Table 2 at three measurement points. Results indicate that, at baseline (T1), there were no 366 
statistically significant differences between groups in the measurements of pain, PHQ-9, HADS or 367 
FFMQ. For each of the scales with clinical cut-offs the selected population baseline mean was above 368 
the clinical cut-offs, PHQ-9 (M= 8.1, SD=4.3), HADS-A (M=9.8, SD= 4.1), HADS-D (M= 5.34, 3.8) 369 
respectively, indicating mild to moderate symptoms of anxiety and depression for both groups.  370 
 371 
A Mann-Whitney U test was conducted to look for statistically significant differences in the 372 
reduction of pain, depression and anxiety scores across treatment conditions. The test identifies a 373 
significant difference in the change score (T1/T2) of perceived pain between the MBDMT group 374 
(Mdn = - 1) and control group (Mdn = .00), U= 128.5, p = .02. The change remained statistically 375 
significant in T1/T3 between the intervention group (Mdn = -1.5) and the control group (Mdn = .00), 376 
U= 81.5, p = .04.  377 
 378 
The reduction of PHQ-9 scores indicates that there were changes in symptoms for the intervention 379 
group (Mdn = -2) which was different from the control group in a statistically significant way (Mdn 380 
= -1), U = 40.5, p = .02. in T1/T2 comparison. The difference was not statistically significant when 381 
T1/T3 was calculated, U = 35.5, p =.18.  382 
 383 
On HADS measures the change score for anxiety and depression was greater than for the control 384 
group in both post intervention time points with reduced scores post intervention for the MBDMT 385 
intervention group, but this change did not reach statistical significance (HADS-A, T1/T2: Mdn = -2 386 
vs Mdn =.00, U = 121.00, p = .06; T1/T3: Mdn = - 4 vs Mdn= -1, U = 78.5, p = .08; HADS-D, 387 
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T1/T2: Mdn = -1.5 vs Mdn = .00, U = 118.5, p = .07; T1/T3: Mdn = -1 vs Mdn= .00, U = 76.5, p = 388 
.11).  389 
 390 
No significant differences between groups was found for Five Facets of Mindfulness scores as 391 
indicated in Table 2. 392 
  393 
Table 3 Reliable change of intervention group using 95% CI for outcome measures pre-intervention 394 
to follow-up (insert here) 395 
 396 
With reference to Table 3, 50% (6/12) of the intervention group participants experienced a reliable 397 
change in pain reduction of at least 2-points. For the other 50% their pain level stayed unchanged. 398 
For 92% (11/12) of participants, their anxiety level reached the clinical cut-off point at baseline for 399 
HADS-A, but follow up measures demonstrated reliable improvement for 73% (8/11) of the 400 
participants. 28% (3/11) of the participants’ anxiety levels changed from clinical to non-clinical 401 
population valuables. Only four participants’ depression levels reached clinical cut-off points at 402 
baseline by both measures PHQ-9 and HADS-D, but at follow up three of these patients (75%) 403 
demonstrated a reliable improvement with regard to depression, changing from the clinical to the 404 
non-clinical population. One patient, from the intervention group included in RCI calculations, 405 
demonstrated a significant increase in anxiety. 406 
 407 
As this pilot study demonstrated statistically significant decrease in depression, the PHQ-9 measure 408 
of depression was used as a primary outcome of the intervention. Based upon the follow up data, 409 
using the means and standard deviation, sample size calculation for a larger RCT was performed. 410 
Calculation for continuous outcome superiority trial with 80% power at an alpha level of .05 411 
suggestes that a total sample of 86 participants was needed to detect clinically important difference 412 
between means. To allow for attrition between end of trial and follow-up, the aim was to recruit 120 413 
patients for an RCT.  414 
3.3. Intervention acceptability, participant adherence and satisfaction  415 
Of the 15 patients who began to participate in the MBDMT group, twelve completed the therapy 416 
course and attended at least eight sessions. The three participants who did not complete the treatment 417 
discontinued early in the study: one moved to a new residence, and two concluded after the first 418 
session that the intervention was not appropriate for them. Four patients completed all ten sessions, 419 
three patients nine sessions and five completed eight sessions.  420 
3.4. Adherence relative to MBDMT protocol 421 
Adherence to the treatment protocol from the dance movement therapist in training was evaluated 422 
through a selection of video recordings from the sessions, looking at different stages of the work 423 
(warm-up, working and closing stage). This was also discussed during regular supervision sessions. 424 
Substantial diversion from the protocol was not observed. The nine working mechanisms that 425 
informed the structure of the intervention were found to be logical and supportive of the development 426 
of the group therapy process. There was, however, some difficulty in the timing of the sessions: the 427 
therapist in training found that more time was needed at the beginning and end of the sessions to 428 
allow for the participants’ verbal discussion.  429 
On the whole, the treatment protocol was easy to follow and responsive to group dynamics offering 430 
alternative choices of techniques.  431 
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4 Discussion 432 
This pilot study suggested that MBDMT was a useful intervention for reducing the pain, depression 433 
and anxiety symptoms of chronic pain patients participating in the study. Results indicate that 434 
offering a DMT group intervention in addition to the usual medical treatment of chronic pain 435 
improved the psychological aspects and reduced pain more than just medical treatment and 436 
physiotherapy. Viewing the results of the present study within the context of other DMT and 437 
mindfulness-based intervention studies, the study offers an interesting addition to the literature, 438 
especially with regards to pain reduction. Results from systematic reviews show that MBIs are 439 
inconsistent in terms of their effect on pain reduction. Results vary from medium to weak 440 
effectiveness, but do reveal a positive impact on perceived pain control with a moderate effect size (g 441 
= 0.58) (Cramer et al., 2012; Bawa et al., 2015).  Note: the goal of MBIs is not to reduce the intensity 442 
of the pain but to improve the patient’s functioning and reduce their general distress; being mindful 443 
has a therapeutic value in its own right (Reiner et al., 2013).  444 
Results from this MBDMT study, however, do suggest a statistically significant reduction in pain 445 
intensity, in contrast with the mindfulness measure where no significant change was observed. While 446 
pain reduction is not the primary goal of the MBDMT intervention, the pain experience of the patient 447 
is validated and the relationship with pain is addressed in the work phase of the therapeutic process. 448 
For 50% of MBDMT participants pain reduction was at least two points on the NRS scale; this is 449 
considered to be a reliable and clinically important change (Farrar et al., 2001). These results are 450 
consistent with the earlier research in DMT for chronic pain patients, in which the theme of working 451 
with the meaning of pain was part of the therapeutic process, and the reduction in pain intensity was 452 
observed (Shim et al., 2017).  453 
The MBDMT intervention preliminary results also suggest that reduction in depression and anxiety 454 
symptoms is possible at least for the small sample of participants with chronic pain involved in this 455 
study. Individual analysis of reliable change for the intervention group indicated reliable 456 
improvement in anxiety symptoms for 73% of patients. For those four patients with moderate and 457 
severe depression, improvement was clinically significant, allowing them to move to a non-clinical 458 
population. These results are consistent with previous research with a similar patient group with 459 
medically unexplained symptoms, including medically unexplained pain, where 65% of participants 460 
involved in a (TBMA) group demonstrated reliable improvement on depression or anxiety measures 461 
(Payne & Brooks, 2017; Payne et al., 2017). These results can also support results from a large-scale 462 
clinical trial on DMT and depression (Hyvönen et al., 2020) and meta-analyses on DMT for 463 
depression (Meekums et al., 2015; Karkou et al., 2019) Also, potentially they add to results from 464 
generic meta-analyses on DMT (Koch et al, 2019). The latter study argues that DMT can improve 465 
psychological conditions by decreasing depression and anxiety levels for patients with somatic 466 
concerns. Results from the current study suggest that this was also true for the participants of the 467 
MBDMT group. 468 
 469 
Findings from this current study may be biased, due to the small sample size and the possibility of a 470 
type II error (low power to detect true effects). However, it is important to mention that the follow-up 471 
measurement (T3) took place two weeks after the beginning of the Covid-19 pandemic in Latvia 472 
(March 2020), and that an overall atmosphere of fear and uncertainty may have influenced the 473 
participants' psycho-emotional state. This, in turn, may have been reflected in the results of the 474 
follow-up anxiety, depression and also pain measures. Also, it is important to acknowledge that 60% 475 
of the study participants had comorbid pain states, which may also have influenced the study results. 476 
The comorbidity of other pain and mental states (depression and anxiety) are characteristic of women 477 
I  r v
w
  Running Title 
 
12 This is a provisional file, not the final typeset article 
with migraine diagnosis and has been reported in previous chronic pain studies (Allais et al., 2020; 478 
Xu et al., 2020), suggesting that mechanism of central sensitization may be a substrate or 479 
consequence of comorbidity (Ashina et al., 2018). 480 
Patients found the experience of being in the MBDMT group to be useful. This was reflected in the 481 
acceptability of the intervention by the participants, which was evaluated as good; 80% of the 482 
participants assigned to the treatment group stayed in the process and attended at least eight out of 483 
ten therapy sessions. The literature suggests that other body-based interventions also show high 484 
completion rates. TBMA, for example, reported a completion rate of 95 percent (Payne & Brooks, 485 
2017), and the resilience-building DMT approach for chronic pain patients was evaluated as helpful 486 
and supporting of a body-mind orientated approach by 68% of participants (Shim et al., 2017).  487 
Still, in the current study, since two patients did not find the intervention appropriate for them and 488 
dropped out of the intervention group after the first therapy session, an assessment of the 489 
intervention’s suitability is needed. Although statistical tests showed no significant difference in 490 
baseline measures between those dropping out and those completing the intervention, HADS anxiety 491 
scores indicate that there were some differences worthy of further analysis. The mean score of 492 
anxiety (9.95) for the group completing the intervention can be seen as borderline with the mean 493 
score of the dropout group (14.00) being a clear outlier. It is possible that the patients with the high 494 
anxiety scores perceived the creative group intervention of MBDMT as too unusual, and involvement 495 
in the therapeutic group as emotionally overwhelming. In a clinical context, an individual dance 496 
movement therapy approach could have been more suitable for these patients. 497 
The evaluation of acceptability of outcome measures indicated that in comparison with HADS, PHQ-498 
9 could show a higher sensitivity in assessing symptoms of depression for this patient group. The 499 
construction of the HADS relies on anhedonia, not on somatic symptoms, and it is sensitive to mild 500 
distress as it excludes symptoms of severe mental illness. PHQ-9 is constructed as a diagnostic tool 501 
for clinical depression and strongly correlates with mental and physical health difficulties (e.g. self-502 
reported disability days and clinical visits) (Anderson et al., 2011) making it an appropriate tool for 503 
use within this study. Furthermore, PHQ-9 was evaluated by patients with unexplained medical 504 
conditions as a more appropriate measurement tool than CORE or HADS in a TBMA pilot study 505 
(Payne, personal communication, December 2020).  Finally, chronic pain patients are often more 506 
interested in the physical representation of their difficulties than the emotional aspects. It therefore, 507 
appeared that PHQ-9 was a more suitable measure of depression for this study, as it captured changes 508 
in the somatic aspects of psycho-emotional distress.  509 
 510 
 511 
Similary, the General Anxiety Disorder (GAD-7) scale was considered a good tool to assess the 512 
anxiety level for the chronic pain patient group. GAD-7 has good psychometric properties and is 513 
sensitive as a clinical outcome measure (National IAPT Programme Team, 2011). Both GAD-7 and 514 
PHQ-9 were also used as measurement tools for depression and anxiety in previous research with a 515 
similar population in The BodyMind Approach (Payne & Brooks, 2017; Payne & Brooks, 2016). It 516 
was therefore decided to use this tool along with PHQ-9 instead of HADS for the larger scale clinical 517 
trial following the pilot.  518 
 519 
Somatic sensitivity may also be relevant to the mindfulness measure. In the present study the FFMQ 520 
was used to assess changes in mindfulness aspects. The FFMQ evaluates the components of 521 
dispositional mindfulness, i.e. the tendency to express mindful attitudes and behaviors in everyday 522 
life (observing experience, using language to describe experience, acting with awareness, being non-523 
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reactive, and being non-judgmental). However, the FFMQ does not distinguish between attention 524 
directed to exteroception, interoception or thoughts (Hanley et al., 2017). Since body awareness is 525 
one of the basic components of the MBDMT intervention, a measurement that detects aspects of 526 
interoceptive body awareness may be more appropriate in future studies. The Multidimensional 527 
Assessment of Interoceptive Awareness (MAIA, Mehling et al., 2012) is one such example: it allows 528 
an assessment of awareness of the body's physiological condition alongside the evaluative 529 
interpretations arising in tandem with that awareness (Mehling, 2016). Mehling (2012) also states 530 
that the MAIA can be helpful in researching mind-body interventions, where the multidimensional 531 
assessment of body awareness can be used to understand which aspects of body awareness contribute 532 
to improvements in clinical outcomes. MAIA has been used as a body awareness assessment tool in 533 
previous research on use of DMT for chronic pain patients (Shim, 2015). 534 
 535 
Mindfulness scores did not show statistically significant changes after the five-week-long MBDMT 536 
intervention. The most commonly used structure in MBI research is eight weeks, with a group 537 
session once a week and an emphasis on regular practice at home (Bawa et al., 2015). The present 538 
length of the MBDMT intervention may not be enough to develop sustainable mindfulness skills. 539 
The ‘dosage’ of this DMT intervention might have been insufficient to create quantitatively 540 
observable changes in mindfulness outcome measures. Another possible interpretation is that the 541 
working mechanisms of the MBDMT model were more closely connected with active therapeutic 542 
factors in DMT than with mindfulness interventions. To research this hypothesis future studies 543 
should involve qualitative and quantitative analysis of therapeutic mechanisms. Future research may 544 
also attempt to answer questions present in the DMT literature (Koch et al., 2019): what do DMT and 545 
mindfulness-based interventions have in common? Additional mindfulness principles that have been 546 
incorporated in DMT through the practice of authentic movement such as the concept of 547 
bodymindfulness (Payne & Brooks, 2019) or “bodyfulness” (Caldwell, 2014) can be further 548 
considered in future research studies. 549 
 550 
At the time of writing, this is the first pilot clinical trial to explore a mindfulness-based model in 551 
DMT for the specific patient group. There are several publications available at the time of writing 552 
this paper: a published case analysis, in which the principles of mindfulness are used within the 553 
context of somatic psychotherapy and DMT as a pathway towards embodiment (Tantia, 2013); a 554 
research study, showing mindfulness skill training as one of the guiding principles of therapeutic 555 
intervention for patients with depression (Pylvänäinen et al., 2015); and therapy models that offer the 556 
perspective of mindfulness meditations, mindful movement practices, e.g. tai chi and yoga as an 557 
important aspect of the DMT intervention (Olmedo, 2020; Sanchez, 2012; Barton, 2011). The 558 
BodyMind Approach (TBMA)® created by Helen Payne (2009a,b) is an integrative approach 559 
underpinned by principles of experiential learning cycles, dance movement psychotherapy and 560 
mindfulness research, created and researched for patients with medically unexplained symptoms 561 
(Payne et al., 2020).  However, the MBDMT is the first model in DMT to be adapted for chronic pain 562 
patients which employs aspects from other models in a unique way.   The model uses mindfulness as 563 
an integral part of the therapeutic process, in which the methodology of mindfulness practice and the 564 
understanding of the working mechanisms are integrated within the creative process of DMT. The 565 
MBDMT model adopts a bi-directional body-mind approach, in which awareness of the body is used 566 
as a physical portal to consciousness (Eddy, 2016), and awareness of the mind is seen as a 567 
metacognitive state – ability to observe, explore and gain the understanding of the processes and 568 
relationships between mind and body, with both aspects (ie body awareness and meta-cognitive 569 
aspects) of mindfulness being equally important (Majore-Dusele & Karkou, 2018). In comparison 570 
with other mindfulness-based interventions, the advantage of the MBDMT is that mindfulness is put 571 
In r v
w
  Running Title 
 
14 This is a provisional file, not the final typeset article 
into action through creative activity, and creative methods enable the participant to fully experience 572 
and to be able to observe the experience at the same time.   573 
 574 
Limitations and future research directions 575 
 576 
The first limitation of the study is the small sample size (n=29) that reduces the generalizability and 577 
statistical power of calculations, and questions the reliability of the quantitative findings. Qualitative 578 
data were used to complement the findings coming from quantitative data and to strengthen the 579 
conclusions regarding the study’s feasibility and the impact of the intervention on specific self-580 
reported measures completed by the participants. The use of self-reported scales is another limitation 581 
of this study. One of the clinical characteristics of the chronic pain patients includes alexithymia – a 582 
decreased ability to identify and describe emotional states and differentiate them from bodily 583 
sensations. This questions the participants’ ability to evaluate their own psycho-emotional states 584 
properly. Although the validity and reliability of the self-report scales used were high, in future 585 
research both subjective and objective measures should be incorporated to increase the validity of the 586 
research findings. Another limitation is the fact that there were only female participants in the study, 587 
questioning the external validity of the study and suggesting a potential selection bias. Also, the 588 
length of the intervention (10 sessions), and the fact, that the therapeutic process was directed by a 589 
dance movement therapist in training, should be considered as possible limitations of the study and as 590 
factors with capacity to influence the results of the study. 591 
 592 
In contrast, the strength of the study is based on the use of randomization and the presence of 593 
homogeneity of the study’s sample.  Further strengths can be assigned to the careful development of 594 




The MBDMT is a feasible and promising intervention for chronic pain patients. The participants in 599 
the MBDMT group reported a significant decrease in pain intensity in comparison with the TAU 600 
control group in both post-intervention measures. A decrease in depression symptoms was significant 601 
in post-intervention measurement. Anxiety also changed in the expected direction for the MBDMT 602 
group. Although results did not reach statistical significance, there was reliable improvement for 73 603 
per cent of the patients attending the intervention group. Scores on mindfulness measures changed in 604 
the expected direction for the MBDMT group, but did not reach statistical significance when 605 
compared with scores from the control group on the same measures. 606 
Still, it was concluded that the pilot study offered sufficient information and preliminary results to 607 
enable the researchers to move to an RCT stage.  It is expected that a larger sample, the inclusion of 608 
an active control, the replication of the group to more than one site delivered by more than one 609 
therapist, and the inclusion of additional somatic outcome measures, will strengthen this pilot study 610 
enabling generalizable findings on the effectiveness of this approach to people with chronic pain.   611 
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Table 1 Baseline participant demographic and clinical characteristics in intervention and control groups 963 
 964 
Characteristics Intervention group  Control group  p 
		 (n=15) (n=14) 		
		 		 		 		
Age M (SD)  40,9 (6,97) 32,2 (4,98) .001a 
		 		 		 		
Localization of pain N (%)  N (%)  		
Headache, migraine 15(100) 14(100) 		
Lower back pain 8(53.3) 5(35.7) .340b  
Musculoskeletal 7(46.7) 2(14.3) .109c  
Fibromyalgia 2(13.3) 1(6.7) 1.0c  
		 		 		 		
Duration of pain 		 		 .431c  
until 1 year 1(6.7) 2(14.3) 		
1-3 years 2(13.3) 0(0) 		
3-5 years 0(0) 1(7.1) 		
5-10 years 2(13.3) 4(28.6) 		
more than 10 10(66.7) 7(50.00) 		
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23 
Pain control strategies 		 		 		
Medication 14(93.3) 13(85.7) .598c 
Physiotherapy/massage 9(60.0) 5(35.7) .191b  
Daily exercise 3(20.0) 2(14.3) 1.0c  
Physical procedures 5(33.3) 4(28.6) 1.0c  
Relaxation/meditation 2(13.3) 1(7.1) 1.0c  
a Mann-Whitney U test; b Pearson Chi-Square; c Fisher Exact test. 		
 965 
Table 2 Means, standard deviation, medians of clinical outcome measures; between group comparison of the 966 
pre/post and pre/follow up change scores.  967 
 968 
Variables    Intervention group (n=12) Control group (n=14)  Mann-Whitney U / p - value 
(Chronbah's 
α) Time  Mean (SD) Mdn (IQR) Mean (SD) Mdn (IQR)       
Pain (NRS) T1 6.00 (1.28) 6 (2) 6.33 (1.22) 6 (3) 
102.5 / 
.35     
  T2 4.83 (1.34) 5 (1) 6.22 (1.56) 6 (2)       
  T3 4.67 (1.44) 4 (2) 6.00 (1.23) 6 (2)       
  (∆)T1 to T2 - 1.17 (.83) - 1.00 (1.75) -.11 (1.17) .00 (1.5)   39.5 / .02*   
  (∆)T1 toT3 - 1.33(.98) -1.5 (1.75) -.33 (1.0) .00 (1.5)     
26.5 / 
.04* 
PHQ-9 T1 8.08 (4.64) 6 (5) 8.67 (4.53) 8 (6) 86.00 / .92     
(.80) T2 4.58 (2.61) 4.5 (4) 8.33 (4.21) 9 (6)       
  T3 4.17 (1.75) 4.5 (2) 6.78 (3.03) 8 (6)       
  (∆)T1 to T2 -3.5 (6.19) -2.00 (3.00) -.33 (2.96) - 1 (2)   40.5 / .02*   
  (∆)T1 to T3 -3.91 (4.12) -2.5 (3.75) -1.89 (3.59) -2 (3.5)     35.5 / .18 
HADS- Anx T1 10.83 (4.39) 11.5 (6) 9.22 (3.89) 9 (5) 56.00 / .15     
(.82) T2 8.08 (3.91) 7.5 (7) 8.56 (3.21) 9 (5)       
  T3 8.17 (2.72) 8.5 (3) 9.22 (3.93) 9 (6)       
  (∆)T1 to T2 -2.75 (3.67) -2 (3.75) -.67 (2.24) .00 (3)   121.0 / .06   
  (∆)T1 to T3 -2.67 (3.31) -4 (4.75) .00 (3.46) -1 (7)     78.5 / .08 
HADS- Depr T1 6.25 (3.72) 5 (5) 4.57 (3.81) 4.5 (5.8) 64.00/ .30     
(.80) T2 4.75 (3.17) 5 (4) 4.22 (2.77) 4 (5)       
  T3 4.42 (2.61) 4 (3) 3.44 (2.83) 3 (6)       
  (∆)T1 to T2 -1.5 (3.70) -1.5 (3.75) .44 (1.94) .00 (6)   118.5 / .07   
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  (∆)T1 to T3 -1.83 (2.72) -1 (4) -.33 (2.00) .00 (3)     76.5 / .11 
FFMQ_full 
scale T1 129.25 (20.04) 127 (32.3) 
138.67 
(15.35) 141 (49) 92.5/.67     
(.89) T2 136.92 (17.05) 135 (15) 137.11 (9.21) 136 (10.5)       
  T3 134.75 (18.69) 136.5 (22.3) 137.11 (21.99) 141 (31.5)       
  (∆)T1 to T2 -7.67 (22.69) -2.5 (21.25) 1.55 (7.52) 2 (8.5)   108.5 / .21   
  (∆)T1 to T3 -5.5 (16.63) -4 (26) 1.55 (10.97) 2 (16.5)     65.00 / .43 
IG – intervention group; CG – control group; (∆) was computed by subtracting pretest from posttest and 969 
pretest from follow up scores; positive values signify an increase and negative values a decrease in the 970 
dependent measure. Results from NRS – Numerous pain rating scale; PHQ-9 – Patient health questionnaire; 971 
HADS – Hospital anxiety and depression scale; FFMQ – Five facets of mindfulness questionnaire – full scales 972 
results. *p< 0.05 973 
Table 3 Reliable change of intervention group using 95% CI for outcome measures pre-intervention 974 
to follow-up.  975 
Outcome variables Recovered Improved Deteriorated Unchanged 
Pain (NRS) n=12 0%  50% (6/12) 0%  50% (6/12) 
PHQ-9 n= 5 80% (4/5) 0% 0% 20% (1/5) 
HADS-D n=4 75% (3/4) 25% (1/4) 0% 0% 
HADS-A n=11 28% (3/11) 45% (5/11) 9% (1/11) 18% (2/11) 
 976 
 977 
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